These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 6208041)
1. A pharmacological study with substance K: evidence for multiple types of tachykinin receptors. Hunter JC; Maggio JE Eur J Pharmacol; 1984 Oct; 105(1-2):149-53. PubMed ID: 6208041 [TBL] [Abstract][Full Text] [Related]
2. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists. Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867 [TBL] [Abstract][Full Text] [Related]
3. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens. Hall JM; Morton IK Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714 [TBL] [Abstract][Full Text] [Related]
4. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder. Burcher E; Buck SH; Lovenberg W; O'Donohue TL J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545 [TBL] [Abstract][Full Text] [Related]
5. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors. Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319 [TBL] [Abstract][Full Text] [Related]
6. FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity. Morimoto H; Murai M; Maeda Y; Hagiwara D; Miyake H; Matsuo M; Fujii T Br J Pharmacol; 1992 May; 106(1):123-6. PubMed ID: 1380378 [TBL] [Abstract][Full Text] [Related]
7. An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes. Bailey SJ; Featherstone RL; Jordan CC; Morton IK Br J Pharmacol; 1986 Jan; 87(1):79-85. PubMed ID: 2420403 [TBL] [Abstract][Full Text] [Related]
8. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder. Hall JM; Flowers JM; Morton IK Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072 [TBL] [Abstract][Full Text] [Related]
9. The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors. Rosell S; Björkroth U; Xu JC; Folkers K Acta Physiol Scand; 1983 Mar; 117(3):445-9. PubMed ID: 6192681 [TBL] [Abstract][Full Text] [Related]
10. Multiple tachykinin binding sites in hamster, rat and guinea-pig urinary bladder. Burcher E; Buck SH Eur J Pharmacol; 1986 Sep; 128(3):165-77. PubMed ID: 3024992 [TBL] [Abstract][Full Text] [Related]
11. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues. Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum. Featherstone RL; Fosbraey P; Morton IK Br J Pharmacol; 1986 Jan; 87(1):73-7. PubMed ID: 2420402 [TBL] [Abstract][Full Text] [Related]
14. Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes. Maggi CA; Patacchini R; Feng DM; Folkers K Eur J Pharmacol; 1991 Jun; 199(1):127-9. PubMed ID: 1716573 [TBL] [Abstract][Full Text] [Related]